drugset / Trial / NCT06833996

The Efficacy of Bakuchiol in Treating PIH

NCT06833996

Completed 22 enrolled Henry Ford Health System
Non-randomizedParallel-groupSingle-blindTreatment

Summary

Post-inflammatory hyperpigmentation (PIH) is an acquired hyper melanosis that occurs after cutaneous inflammation or injury frequently affecting darker skinned individuals. Bakuchiol is derived from plants and has inhibitory effects on melanin synthesis, which makes it a promising therapeutic intervention in the management of PIH. This study aims to evaluate the efficacy of bakuchiol in treating post inflammatory hyperpigmentation using the investigators previously validated model in comparison to acne induced PIH.

Timeline

Start
2016-02-22
Primary completion
2018-05-23
Completion
2019-05-05

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Bakuchiol Small molecule Topical